SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
JSON
Havervall S, Jernbom Falk A, Klingström J, Ng H, Greilert-Norin N, Gabrielsson L, Salomonsson AC, Isaksson E, Rudberg AS, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Christ W, Olausson M, Hedhammar M, Tegel H, Mangsbo S, Phillipson M, Månberg A, Hober S, Nilsson P, Thålin C
PLoS One 17 (1) e0262169
[2022-01-12; online 2022-01-12]
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
PubMed 35020778
DOI 10.1371/journal.pone.0262169
Crossref 10.1371/journal.pone.0262169